Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: a randomized controlled trial

2/5 Late treatment study

Hernandez-Cardenas et al., medRxiv, doi:10.1101/2021.02.01.21250371 (Preprint)
Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: a randomized controlled trial

Source PDF Share Tweet

Very late stage RCT with 214 patients, mean SpO₂ 65%, 162 on mechanical ventilation, showing no signficant difference in mortality.

Patients not intubated at baseline show greater improvement, HR 0.43 [0.09-2.03].

Table 4 shows different results to the abstract - table 4 adjusted HR 0.80 [0.51-1.23], abstract HR 0.88 [0.51-1.53]. There was no significant difference in severe adverse events.

Hernandez-Cardenas et al., 2/5/2021, Randomized Controlled Trial, Mexico, North America, preprint, 6 authors.

risk of death, 12.0% lower, RR 0.88, p = 0.66, treatment 106, control 108.

risk of death, 57.0% lower, RR 0.43, p = 0.29, subgroup not intubated at baseline.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. For an individual study the most serious outcome may have a smaller number of events and lower statistical signficance, however this provides the strongest evidence for the most serious outcomes when combining the results of many trials.

All 344 studies Meta Analysis

Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.

Submit